BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1311787)

  • 1. [Protective effect of proton pump inhibitor on the gastric mucosa].
    Kawano S; Tsuji S; Masuda E; Hayashi N; Tsujii M; Michida T; Kobayashi I; Fusamoto H; Kamada T
    Nihon Rinsho; 1992 Jan; 50(1):33-8. PubMed ID: 1311787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of proton pump inhibitor on gastric mucosa hemodynamics and tissue oxygenation in anesthetized rats.
    Kawano S; Tanimura H; Sato N; Tsuji S; Takei Y; Ogihara T; Nagano K; Fusamoto H; Kamada T
    Eur J Pharmacol; 1992 Jan; 211(1):55-60. PubMed ID: 1319908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnifying endoscopic observation on the effect of a proton pump inhibitor on the healing process of gastric ulcer].
    Sakaki N
    Nihon Rinsho; 1992 Jan; 50(1):86-93. PubMed ID: 1311790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats].
    Imai S; Itoh M; Yokoyama Y; Joh T; Takeuchi T
    Nihon Rinsho; 1992 Jan; 50(1):39-44. PubMed ID: 1311788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
    Fryklund J; Wallmark B
    J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
    Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
    Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats.
    Goto H; Sugiyama S; Tsukamoto Y; Kuroiwa M; Ohara A; Hoshino H; Nakazawa S; Ozawa T
    Arzneimittelforschung; 1991 Jun; 41(6):635-7. PubMed ID: 1657010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors].
    Tsukamoto Y; Niwa Y; Arisawa T
    Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric H+, K+ adenosine triphosphatase (ATPase) by substituted naphthylalkylimidazoles.
    Serrato C; Waterbury D; Loury D; Smith W
    Proc West Pharmacol Soc; 1989; 32():249-53. PubMed ID: 2550945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
    Nagaya H; Satoh H; Kubo K; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
    Okabe S
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):351-60. PubMed ID: 2873085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
    Yukawa K; Yukawa E
    Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastric H+,K+-ATPase: the site of action of omeprazole.
    Sachs G; Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of proton-pump inhibitors on the healing process of peptic ulcers--electronic endoscopic study].
    Miyahara T; Kawaguchi A; Nogao S; Niwa H
    Nihon Rinsho; 1992 Jan; 50(1):98-103. PubMed ID: 1347335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.